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FINAL EXAMINATION DURATION 
PHA210 – Pharmacology 1 
 
Reading Time: 10 minutes 
Writing Time: 180 minutes 
 
INSTRUCTIONS TO CANDIDATES 
 
The examination has 2 (A and B) Sections: 
Section A contains Forty (40) Multiple Choice Questions.  Answer all questions on the Faculty/School 
supplied Multiple Choice Answer Sheet.  Total marks allocated: Twenty (20). 
Suggested time allocation: One (1) hour. 
Section B contains Ten (10) Extended-Answer Questions.  Answer any Eight (8) questions only in the 
20-page Booklet provided.  Total marks allocated: Eighty (80). 




You may begin writing from the commencement of the examination session.  The reading time 
indicated above is provided as a guide only. 
This is a CLOSED BOOK examination 
No calculators are permitted 
No handwritten notes are permitted 
No dictionaries are permitted 
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No additional printed material is permitted 
 
1 x 20 Page Book 
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Section A 
Multiple Choice Questions 
Total No. of Marks for this Section: 20 
 
Please write the answers for this section on the 100-MCQ Answer Sheet provided. 
Ensure that your name and student number have been written on the answer sheet. 
 
Answer ALL (40) questions 
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Section B 
Extended-Answer Questions 
Total No. of Marks for this Section: 80 
 
Please answer this section in the 20-page Answer Booklet provided.  Ensure that your 
name and student number have been written on the front page of the answer booklet. 
 
Answer any EIGHT (8) questions. 




Sometimes the adverse or unwanted effects of a drug can be reduced by the use of 
a more selective drug.  Use the following examples to explain how this has been 
achieved.  Give an example of adverse or unwanted effects which may be reduced 
in each case. 
a. The use of bisoprolol in place of propranolol for heart failure. 
b. The use of terazosin in place of phenoxybenzamine for hypertension. 
c. The use of salbutamol in place of isoprenaline for asthma. 
d. The use of pyridostigmine in place of physostigmine for Myasthenia gravis. 






Describe the mechanism(s) of action and discuss how each of these drugs is useful 
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Question 3 
a. In a diagram, draw a LINEAR plasma concentration versus time elimination 
curve and an EXPONENTIAL plasma concentration versus time elimination 
curve.  Discuss the information you can acquired from these curves with regard 
to the elimination process of a particular drug. 
 (5 marks) 
b. Define the term “Volume of distribution” for a drug.  Explain how this 
pharmacokinetic parameter can be influenced by plasma protein binding, and 
how this pharmacokinetic parameter can influence the clearance (CL) and 
elimination half-life (t½) of a drug. 







a. Describe the mechanism by which digoxin affects myocardial contractility. 
 (4 marks) 
b. What would be the expected effects on these following parameters when a 
patient with congestive heart failure is treated with digoxin?  Include in your 
answer a brief explanation of how they occur. 
i. Heart rate (2 marks) 
ii. Ventricular End Diastolic Volume (EDV) (2 marks) 
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Question 5 (multiple topics) 
a. Describe the mechanism of action of glyceryl trinitrate (GTN) in reducing heart 
workload and relieving angina pectoris. 
 (5 marks) 
b. What is meant by the term ‘pH-dependence’ with respect to local anaesthetics? 






Question 6  









a. What disorder is Mr SM likely to be suffering from?         (1 mark) 
b. Describe the mechanisms of action of the active ingredients in Vytorin and 
explain how they benefit Mr SM. 
 (6 marks) 
c. What are the consequences if Mr SM is not compliant with taking this 
medication? 
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Question 7 (multiple topics) 
a. Compare the mechanisms of ranitidine and pantoprazole in reducing gastric 
acidity.  Which is the more effective?  Explain your answer. 
 (5 marks) 
b. Are there any differences amongst the calcium-channel blocking agents?  
Explain your answer and give examples.  







Differentiate between unfractionated heparin and warfarin (both anticoagulants) with 
respect to the following: 
a. Mechanism of action.            (5 marks) 
b. Route of administration.            (1 mark) 
c. Speed of onset.  You are required to explain what causes the difference. 
 (3 marks) 
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Question 9  







a. What disorder is Ms PK likely to be suffering from? (1 mark) 
b. Describe in detail the mechanisms of action of the active ingredients in 
AvaproHCT and explain how they benefit Ms PK. 
 (6 marks) 
c. Therapy with hydrochlorothiazide may adversely affect electrolyte balance.  
Describe ONE (1) major concern and provide TWO (2) possible options for 
preventing this adverse effect. 






Question 10  
These following agents have been used as antiplatelets.  Briefly describe their 
mechanisms of action: 








End of Sections B 
 
End of Exam Paper 
 
 
